[Analytical choices for biological tests in thrombotic pathology].

Abstract excerpt

The knowledge of genetic and occurred risk factors allows us to propose laboratory investigations in patients with thromboembolism (TE) to evaluate the risk for recurrence. Beside coagulation inhibitor deficiencies accounting for less than 10% of cases, factor V Leiden and prothrombin G20210A mutations are found in around 30% and 10% respectively. Increased factor VIII and hyperhomocysteinemia resulting from...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Risk Factors
• Share to Clinical Laboratory Techniques
• Share to Factor V